Literature DB >> 2766894

In-vivo effects of ivermectin on Rhipicephalus appendiculatus: the influence of tick feeding patterns and drug pharmacokinetics.

H C Jackson1, M P Chesterman.   

Abstract

Sublethal effects seen amongst Rhipicephalus appendiculatus feeding on ivermectin-treated rabbits were diverse and dependent both on drug dose, pharmacokinetics and tick feeding patterns: changes in drug formulation, the time of infestation relative to treatment, and the tick instar used, profoundly influenced acaricidal activity. Death was a sequel to paralysis only if tick feeding was interrupted for sufficient time to produce irreversible dehydration. Concurrent pharmacokinetic investigations revealed that, for the larvae of R. appendiculatus, the mean critical lethal dose of ivermectin imbibed over a 5-day engorgement period was 3500 micrograms/kg. This quantity of ivermectin was achieved in the blood-meals of larvae feeding on rabbits treated subcutaneously with a single dose of Ivomec injection (MSD)* greater than or equal to 800 micrograms/kg, provided infestation took place within 24 h of treatment. At lower drug doses, or if larval infestations were delayed for greater than 24 h post-treatment, the quantity of circulating ivermectin (and thus imbibed by the tick larvae) fell below 3500 micrograms/kg and an increasing percentage of larvae successfully engorged and detached. More than 90% of such larvae moulted to the nymphal stage. Nymphae and larvae exhibited similar susceptibility to ivermectin on treated rabbits which could be explained by similar feeding patterns. However, adult female and male ticks were markedly less susceptible and interpretation of ivermectin-induced effects was more complex.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2766894     DOI: 10.1007/BF01270431

Source DB:  PubMed          Journal:  Exp Appl Acarol        ISSN: 0168-8162            Impact factor:   2.132


  9 in total

1.  Ivermectin: an update.

Authors:  W C Campbell
Journal:  Parasitol Today       Date:  1985-07

2.  Pharmacokinetic studies of ivermectin: effects of formulation.

Authors:  P K Lo; D W Fink; J B Williams; J Blodinger
Journal:  Vet Res Commun       Date:  1985-09       Impact factor: 2.459

3.  A comparative investigation of experimental prophylactic methods for tick-borne diseases transmitted by Ixodes ricinus.

Authors:  S M Taylor; C T Elliott; J Kenny; J Blanchflower
Journal:  Br Vet J       Date:  1986 Sep-Oct

Review 4.  Ivermectin: a review of efficacy and safety.

Authors:  W C Campbell; G W Benz
Journal:  J Vet Pharmacol Ther       Date:  1984-03       Impact factor: 1.786

5.  Control of ticks systemically with Merck MK-933, an avermectin.

Authors:  R O Drummond; T M Whetstone; J A Miller
Journal:  J Econ Entomol       Date:  1981-08       Impact factor: 2.381

6.  Potentiation of salivary fluid secretion in ixodid ticks: a new receptor system for gamma-aminobutyric acid.

Authors:  P J Lindsay; W R Kaufman
Journal:  Can J Physiol Pharmacol       Date:  1986-08       Impact factor: 2.273

7.  Control of induced infestations of adult Amblyomma hebraeum with sustained release ivermectin.

Authors:  M D Soll; I H Carmichael; S J Gross
Journal:  Onderstepoort J Vet Res       Date:  1987-03       Impact factor: 1.792

8.  The effect of avermectins on feeding, salivary fluid secretion, and fecundity in some ixodid ticks.

Authors:  W R Kaufman; S G Ungarian; A E Noga
Journal:  Exp Appl Acarol       Date:  1986-04       Impact factor: 2.132

9.  The maintenance and survival of Theileria annulata in colonies of Hyalomma anatolicum anatolicum.

Authors:  A R Walker; J D Fletcher; S B McKellar; L J Bell; C G Brown
Journal:  Ann Trop Med Parasitol       Date:  1985-04
  9 in total
  1 in total

1.  Effects of the avermectin analogue MK-243 on vitellogenesis and reproduction in the ixodid tick, Amblyomma hebraeum.

Authors:  M D Lunke; W R Kaufman
Journal:  Exp Appl Acarol       Date:  1992-03       Impact factor: 2.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.